Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma.

被引：103

作者：

Jazaeri, Amir A.

Zsiros, Emese

Amaria, Rodabe Navroze

Artz, Andrew S.

Edwards, Robert P.

Wenham, Robert Michael

Slomovitz, Brian M.

Walther, Axel

Thomas, Sajeve Samuel

Chesney, Jason Alan

Morris, Robert

Matsuo, Koji

Gaillard, Stephanie

Rose, Peter Graham

Garcia Donas, Jesus

Tromp, Jacqueline Maria

Tavakkoli, Fatemeh

Li, Huiling

Fardis, Maria

Monk, Bradley J.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Rosewel Pk Canc Inst, Buffalo, NY USA

[3] Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA

[4] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15213 USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[6] Univ Miami, Miami, FL USA

[7] Univ Hosp Bristol, Bristol, Avon, England

[8] Univ Florida, Hlth Canc Ctr, Orlando Hlth, Orlando, FL USA

[9] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA

[10] Wayne State Univ, Barbara A Karmanos Canc Ctr, Detroit, MI USA

[11] Univ Southern Calif, Los Angeles Cty Hosp, Los Angeles, CA USA

[12] Johns Hopkins Sch Med, Baltimore, MD USA

[13] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[14] Hosp Univ Madrid Sanchinarro, Madrid, Spain

[15] Acad Med Ctr, Amsterdam, Netherlands

[16] Iovance Biotherapeut Inc, San Carlos, CA USA

[17] Univ Arizona, Canc Ctr, Dign Hlth, St Josephs Hosp & Med Ctr, Phoenix, AZ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.2538

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2538

引用

页数：2